Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The SURMOUNT-5 trial is one of several trials under the SURMOUNT trial program which evaluates the efficacy and safety of tirzepatide for the treatment of obesity
Keyoung served as President, Asia of Catalyst Biosciences Inc., a hemophilia and ophthalmology-focused clinical stage company, from December 2013 to June 2015, and as Managing Director and Head of Pan-Asia at Burrill & Company LLC, a venture capital firm, where he oversaw investments in private and public biotechnology and medtech companies from 2008 to 2013
50 Gram Dose The maximum dosage level reserved for severe health conditions or intensive detoxification protocols
Estrogen exposure, pregnancy, and the postpartum period raise baseline gallstone risk
Boost energy
US$ 24.21
US$ 26.56
US$ 20.39
US$ 20.25
US$ 29.39
US$ 24.13
US$ 23.08
